Analysts at StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX opened at $0.00 on Thursday. Athersys has a 12 month low of $0.01 and a 12 month high of $1.99. […]